Hygeia Healthcare Holdings Co., Limited (6078.HK)
6078.HK Stock Price Chart
Explore Hygeia Healthcare Holdings Co., Limited interactive price chart. Choose custom timeframes to analyze 6078.HK price movements and trends.
6078.HK Company Profile
Discover essential business fundamentals and corporate details for Hygeia Healthcare Holdings Co., Limited (6078.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
29 Jun 2020
Employees
8.17K
Website
https://www.hygeia-group.com.cnCEO
Yiwen Zhu
Description
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offer oncology healthcare services, such as tumor screening and genetic diagnosis, radiotherapy, surgery, chemotherapy, immunotherapy, targeted therapy, oncology rehabilitation, nutrition, and hospice care. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital and corporate management, and supply chain services. As of December 31, 2021, it operated or managed a network of 12 oncology-focused hospitals in 9 cities in 7 Provinces in the People's Republic of China. Hygeia Healthcare Holdings Co., Limited was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
6078.HK Financial Timeline
Browse a chronological timeline of Hygeia Healthcare Holdings Co., Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Aug 2025
EPS came in at $0.47 surpassing the estimated $0.43 by +8.82%, while revenue for the quarter reached $2.18B , missing expectations by -0.56%.
Earnings released on 27 Mar 2025
EPS came in at $0.36 falling short of the estimated $0.70 by -48.30%, while revenue for the quarter reached $2.20B , missing expectations by -23.36%.
Earnings released on 30 Aug 2024
EPS came in at $0.65 falling short of the estimated $0.71 by -7.76%, while revenue for the quarter reached $2.56B , missing expectations by -10.53%.
Earnings released on 27 Mar 2024
EPS came in at $0.61 surpassing the estimated $0.59 by +2.86%, while revenue for the quarter reached $2.56B , beating expectations by +0.56%.
Earnings released on 29 Aug 2023
EPS came in at $0.57 falling short of the estimated $0.58 by -1.88%, while revenue for the quarter reached $1.90B , missing expectations by -4.01%.
Dividend declared on 30 Jun 2023
A dividend of $0.16 per share was announced, adjusted to $0.16. The dividend was paid on 27 Jul 2023.
Earnings released on 20 Mar 2023
EPS came in at $0.47 falling short of the estimated $0.54 by -14.11%, while revenue for the quarter reached $1.90B , missing expectations by -1.69%.
Earnings released on 1 Sept 2022
EPS came in at $0.43 falling short of the estimated $0.45 by -4.40%, while revenue for the quarter reached $1.79B , beating expectations by +9.21%.
Earnings released on 30 Mar 2022
EPS came in at $0.48 , while revenue for the quarter reached $1.69B .
Earnings released on 23 Aug 2021
EPS came in at $0.38 , while revenue for the quarter reached $1.12B .
Dividend declared on 30 Jun 2021
A dividend of $0.14 per share was announced, adjusted to $0.14. The dividend was paid on 26 Jul 2021.
Earnings released on 30 Mar 2021
EPS came in at $0.32 , while revenue for the quarter reached $913.88M .
6078.HK Stock Performance
Access detailed 6078.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.